يعرض 1 - 20 نتائج من 102 نتيجة بحث عن '"Traum, Avram"', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Book
  6. 6
    Book
  7. 7
  8. 8
    Academic Journal
  9. 9
    Book
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal
  14. 14
    Academic Journal

    المساهمون: Department of Pediatrics, Division of Nephrology

    المصدر: Pediatric transplantation ; 21 ; 3

    مصطلحات موضوعية: Hepatology, Nephrology, Pediatrics, Surgery

    Relation: Link to Article in PubMed; https://doi.org/10.1111/petr.12901; Pediatr Transplant. 2017 May;21(3). doi:10.1111/petr.12901. Epub 2017 Mar 5. Link to article on publisher's site; 1397-3142 (Linking); http://hdl.handle.net/20.500.14038/43547; https://escholarship.umassmed.edu/peds_pp/117; peds_pp/117

  15. 15
    Academic Journal

    وصف الملف: application/pdf

    Relation: Engen, Rachel M.; Weng, Patricia L.; Shih, Weiwen; Patel, Hiren P.; Richardson, Kelsey; Dowdrick, Shauna L.; Ashoor, Isa F.; Misurac, Jason; Traum, Avram Z.; Semanik, Michael G.; Jain, Namarata G.; Mansuri, Asifhusen; Sreedharan, Rajasree (2022). "Outcomes of granulocyte colony-stimulating factor use in pediatric kidney transplant recipients: A Pediatric Nephrology Research Consortium study." Pediatric Transplantation (3): n/a-n/a.; https://hdl.handle.net/2027.42/172325; Pediatric Transplantation; Khalil MAM, Khalil MAU, Khan TFT, Tan J. Drug-induced hematological cytopenia in kidney transplantation and the challenges it poses for kidney transplant physicians. J Transplant. 2018; 2018: 1 - 22. doi:10.1155/2018/9429265; Turgeon N, Hovingh GK, Fishman JA, et al. Safety and efficacy of granulocyte colony-stimulating factor in kidney and liver transplant recipients. Transpl Infect Dis. 2000; 2 ( 1 ): 15 - 21. Accessed May 1, 2018. http://www.ncbi.nlm.nih.gov/pubmed/11429005; Mehta HM, Malandra M, Corey SJ. G-CSF and GM-CSF in neutropenia. J Immunol. 2015; 195 ( 4 ): 1341 - 1349. doi:10.4049/jimmunol.1500861; Hurst FP, Belur P, Nee R, et al. Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States renal data system. Transplantation. 2011; 92 ( 1 ): 36 - 40. doi:10.1097/TP.0b013e31821c1e70; Zafrani L, Truffaut L, Kreis H, et al. Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study. Am J Transplant. 2009; 9 ( 8 ): 1816 - 1825. doi:10.1111/j.1600-6143.2009.02699.x; Becker-Cohen R, Ben-Shalom E, Rinat C, Feinstein S, Geylis M, Frishberg Y. Severe neutropenia in children after renal transplantation: incidence, course, and treatment with granulocyte colony-stimulating factor. Pediatr Nephrol. 2015; 30 ( 11 ): 2029 - 2036. doi:10.1007/s00467-015-3113-7; Winston DJ, Foster PF, Somberg KA, et al. Randomized, placebo-controlled, double-blind, multicenter trial of efficacy and safety of granulocyte colony-stimulating factor in liver transplant recipients. Transplantation. 1999; 68 ( 9 ): 1298 - 1304. Accessed May 1, 2018. http://www.ncbi.nlm.nih.gov/pubmed/10573067; Larson R Use of granulocyte colony stimulating factors in adult patients with chemotherapy-induced neutropenia and conditions other than acute leukemia, myelodysplastic syndrome, and hematopoietic cell transplantation - UpToDate. UpToDate. Accessed March 31, 2021.; Schmaldienst S, Bekesi G, Deicher R, Franz M, Hörl WH, Pohanka E. Recombinant human granulocyte colony-stimulating factor after kidney transplantation: a retrospective analysis to evaluate the benefit or risk of immunostimulation. Transplantation. 2000; 69 ( 4 ): 527 - 531. Accessed May 1, 2018. http://www.ncbi.nlm.nih.gov/pubmed/10708106; Hamel S, Kuo V, Sawinski D, et al. Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantation. Clin Transplant. 2019; 33 ( 6 ): e13541. doi:10.1111/ctr.13541; Vrtovec B, Haddad F, Pham M, et al. Granulocyte colony-stimulating factor therapy is associated with a reduced incidence of acute rejection episodes or allograft vasculopathy in heart transplant recipients. Transplant Proc. 2013; 45 ( 6 ): 2406 - 2409. doi:10.1016/j.transproceed.2013.01.106; Peddi VR, Hariharan S, Schroeder TJ, First MR. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients. Clin Transplant. 1996; 10 ( 1 Pt 1 ): 20 - 23. Accessed May 1, 2018. http://www.ncbi.nlm.nih.gov/pubmed/8652892; Jha A, Ghoz H, James N. Severe agranulocytosis following simultaneous administration of chlorpromazine and trimethoprim-sulfamethoxazole in a patient with sepsis. A possible toxic combination. Case Rep Med. 2016; 2016: 1 - 3. doi:10.1155/2016/5653497; Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009; 20 ( 3 ): 629 - 637. doi:10.1681/ASN.2008030287; North American Pediatric Renal Trials and Collaborative Studies. NAPRTCS 2014 Annual Transplant Report. Accessed March 31, 2021. https://naprtcs.org/system/files/2014_Annual_Transplant_Report.pdf Published 2014; Hartmann LC, Tschetter LK, Habermann TM, et al. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. N Engl J Med. 1997; 336 ( 25 ): 1776 - 1780. doi:10.1056/nejm199706193362502

  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
  19. 19
    Academic Journal
  20. 20
    Academic Journal